The global Menopause Drugs market was valued at US$ 9860.3 million in 2023 and is anticipated to reach US$ 11850 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.

Menopause Drugs Market

Menopause is the end of a woman’s menstrual cycles. The term can describe any of the changes you go through just before or after you stop having your period, marking the end of your reproductive years.

The menopause drugs market is primarily driven by the increasing aging population of women and the growing awareness of menopausal symptoms and their management. As women approach menopause, they often experience symptoms like hot flashes, mood swings, and sleep disturbances, leading to a rising demand for effective treatments. Hormone replacement therapy (HRT) and non-hormonal drugs are commonly prescribed to alleviate these symptoms, contributing to market growth. However, challenges in this market include concerns related to the long-term use of hormone therapy, potential side effects, and the need for personalized treatment plans. There is ongoing research to develop safer and more tailored therapies for menopausal symptom management. Additionally, cultural and societal factors can influence the acceptance and utilization of menopause drugs, making it important for pharmaceutical companies to address these aspects to succeed in the market.

This report aims to provide a comprehensive presentation of the global market for Menopause Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menopause Drugs.

Report Scope

The Menopause Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Menopause Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Menopause Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Menopause Drugs Market Report

Report Metric	Details
Report Name	Menopause Drugs Market
Accounted market size in 2023	US$ 9860.3 million
Forecasted market size in 2030	US$ 11850 million
CAGR	2.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Parenteral Transdermal Oral Others
Segment by Application	Hospitals Drugstores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Viatris, Bayer, Teva, Novartis, Abbott, Roche, Endo International, Ipsen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Menopause Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Menopause Drugs Market growing?

Ans: The Menopause Drugs Market witnessing a CAGR of 2.6% during the forecast period 2024-2030.

What is the Menopause Drugs Market size in 2030?

Ans: The Menopause Drugs Market size in 2030 will be US$ 11850 million.

Who are the main players in the Menopause Drugs Market report?

Ans: The main players in the Menopause Drugs Market are Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Viatris, Bayer, Teva, Novartis, Abbott, Roche, Endo International, Ipsen

What are the Application segmentation covered in the Menopause Drugs Market report?

Ans: The Applications covered in the Menopause Drugs Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Menopause Drugs Market report?

Ans: The Types covered in the Menopause Drugs Market report are Parenteral, Transdermal, Oral, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Menopause Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Parenteral

1.2.3 Transdermal

1.2.4 Oral

1.2.5 Others

1.3 Market by Application

1.3.1 Global Menopause Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Menopause Drugs Market Perspective (2019-2030)

2.2 Menopause Drugs Growth Trends by Region

2.2.1 Global Menopause Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Menopause Drugs Historic Market Size by Region (2019-2024)

2.2.3 Menopause Drugs Forecasted Market Size by Region (2025-2030)

2.3 Menopause Drugs Market Dynamics

2.3.1 Menopause Drugs Industry Trends

2.3.2 Menopause Drugs Market Drivers

2.3.3 Menopause Drugs Market Challenges

2.3.4 Menopause Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Menopause Drugs Players by Revenue

3.1.1 Global Top Menopause Drugs Players by Revenue (2019-2024)

3.1.2 Global Menopause Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Menopause Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Menopause Drugs Revenue

3.4 Global Menopause Drugs Market Concentration Ratio

3.4.1 Global Menopause Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Menopause Drugs Revenue in 2023

3.5 Menopause Drugs Key Players Head office and Area Served

3.6 Key Players Menopause Drugs Product Solution and Service

3.7 Date of Enter into Menopause Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Menopause Drugs Breakdown Data by Type

4.1 Global Menopause Drugs Historic Market Size by Type (2019-2024)

4.2 Global Menopause Drugs Forecasted Market Size by Type (2025-2030)

5 Menopause Drugs Breakdown Data by Application

5.1 Global Menopause Drugs Historic Market Size by Application (2019-2024)

5.2 Global Menopause Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Menopause Drugs Market Size (2019-2030)

6.2 North America Menopause Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Menopause Drugs Market Size by Country (2019-2024)

6.4 North America Menopause Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Menopause Drugs Market Size (2019-2030)

7.2 Europe Menopause Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Menopause Drugs Market Size by Country (2019-2024)

7.4 Europe Menopause Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Menopause Drugs Market Size (2019-2030)

8.2 Asia-Pacific Menopause Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Menopause Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Menopause Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Menopause Drugs Market Size (2019-2030)

9.2 Latin America Menopause Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Menopause Drugs Market Size by Country (2019-2024)

9.4 Latin America Menopause Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Menopause Drugs Market Size (2019-2030)

10.2 Middle East & Africa Menopause Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Menopause Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Menopause Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eli Lilly

11.1.1 Eli Lilly Company Detail

11.1.2 Eli Lilly Business Overview

11.1.3 Eli Lilly Menopause Drugs Introduction

11.1.4 Eli Lilly Revenue in Menopause Drugs Business (2019-2024)

11.1.5 Eli Lilly Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Menopause Drugs Introduction

11.2.4 Pfizer Revenue in Menopause Drugs Business (2019-2024)

11.2.5 Pfizer Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Detail

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Menopause Drugs Introduction

11.3.4 AbbVie Revenue in Menopause Drugs Business (2019-2024)

11.3.5 AbbVie Recent Development

11.4 Novo Nordisk

11.4.1 Novo Nordisk Company Detail

11.4.2 Novo Nordisk Business Overview

11.4.3 Novo Nordisk Menopause Drugs Introduction

11.4.4 Novo Nordisk Revenue in Menopause Drugs Business (2019-2024)

11.4.5 Novo Nordisk Recent Development

11.5 Merck KGaA

11.5.1 Merck KGaA Company Detail

11.5.2 Merck KGaA Business Overview

11.5.3 Merck KGaA Menopause Drugs Introduction

11.5.4 Merck KGaA Revenue in Menopause Drugs Business (2019-2024)

11.5.5 Merck KGaA Recent Development

11.6 Viatris

11.6.1 Viatris Company Detail

11.6.2 Viatris Business Overview

11.6.3 Viatris Menopause Drugs Introduction

11.6.4 Viatris Revenue in Menopause Drugs Business (2019-2024)

11.6.5 Viatris Recent Development

11.7 Bayer

11.7.1 Bayer Company Detail

11.7.2 Bayer Business Overview

11.7.3 Bayer Menopause Drugs Introduction

11.7.4 Bayer Revenue in Menopause Drugs Business (2019-2024)

11.7.5 Bayer Recent Development

11.8 Teva

11.8.1 Teva Company Detail

11.8.2 Teva Business Overview

11.8.3 Teva Menopause Drugs Introduction

11.8.4 Teva Revenue in Menopause Drugs Business (2019-2024)

11.8.5 Teva Recent Development

11.9 Novartis

11.9.1 Novartis Company Detail

11.9.2 Novartis Business Overview

11.9.3 Novartis Menopause Drugs Introduction

11.9.4 Novartis Revenue in Menopause Drugs Business (2019-2024)

11.9.5 Novartis Recent Development

11.10 Abbott

11.10.1 Abbott Company Detail

11.10.2 Abbott Business Overview

11.10.3 Abbott Menopause Drugs Introduction

11.10.4 Abbott Revenue in Menopause Drugs Business (2019-2024)

11.10.5 Abbott Recent Development

11.11 Roche

11.11.1 Roche Company Detail

11.11.2 Roche Business Overview

11.11.3 Roche Menopause Drugs Introduction

11.11.4 Roche Revenue in Menopause Drugs Business (2019-2024)

11.11.5 Roche Recent Development

11.12 Endo International

11.12.1 Endo International Company Detail

11.12.2 Endo International Business Overview

11.12.3 Endo International Menopause Drugs Introduction

11.12.4 Endo International Revenue in Menopause Drugs Business (2019-2024)

11.12.5 Endo International Recent Development

11.13 Ipsen

11.13.1 Ipsen Company Detail

11.13.2 Ipsen Business Overview

11.13.3 Ipsen Menopause Drugs Introduction

11.13.4 Ipsen Revenue in Menopause Drugs Business (2019-2024)

11.13.5 Ipsen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Menopause Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Parenteral

Table 3. Key Players of Transdermal

Table 4. Key Players of Oral

Table 5. Key Players of Others

Table 6. Global Menopause Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Menopause Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Menopause Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Menopause Drugs Market Share by Region (2019-2024)

Table 10. Global Menopause Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Menopause Drugs Market Share by Region (2025-2030)

Table 12. Menopause Drugs Market Trends

Table 13. Menopause Drugs Market Drivers

Table 14. Menopause Drugs Market Challenges

Table 15. Menopause Drugs Market Restraints

Table 16. Global Menopause Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Menopause Drugs Market Share by Players (2019-2024)

Table 18. Global Top Menopause Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopause Drugs as of 2023)

Table 19. Ranking of Global Top Menopause Drugs Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Menopause Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Menopause Drugs Product Solution and Service

Table 23. Date of Enter into Menopause Drugs Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Menopause Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Menopause Drugs Revenue Market Share by Type (2019-2024)

Table 27. Global Menopause Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Menopause Drugs Revenue Market Share by Type (2025-2030)

Table 29. Global Menopause Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Menopause Drugs Revenue Market Share by Application (2019-2024)

Table 31. Global Menopause Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Menopause Drugs Revenue Market Share by Application (2025-2030)

Table 33. North America Menopause Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Menopause Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Menopause Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Menopause Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Menopause Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Menopause Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Menopause Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Menopause Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Menopause Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Menopause Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Menopause Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Menopause Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Menopause Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Menopause Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Menopause Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 48. Eli Lilly Company Detail

Table 49. Eli Lilly Business Overview

Table 50. Eli Lilly Menopause Drugs Product

Table 51. Eli Lilly Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 52. Eli Lilly Recent Development

Table 53. Pfizer Company Detail

Table 54. Pfizer Business Overview

Table 55. Pfizer Menopause Drugs Product

Table 56. Pfizer Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 57. Pfizer Recent Development

Table 58. AbbVie Company Detail

Table 59. AbbVie Business Overview

Table 60. AbbVie Menopause Drugs Product

Table 61. AbbVie Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 62. AbbVie Recent Development

Table 63. Novo Nordisk Company Detail

Table 64. Novo Nordisk Business Overview

Table 65. Novo Nordisk Menopause Drugs Product

Table 66. Novo Nordisk Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 67. Novo Nordisk Recent Development

Table 68. Merck KGaA Company Detail

Table 69. Merck KGaA Business Overview

Table 70. Merck KGaA Menopause Drugs Product

Table 71. Merck KGaA Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 72. Merck KGaA Recent Development

Table 73. Viatris Company Detail

Table 74. Viatris Business Overview

Table 75. Viatris Menopause Drugs Product

Table 76. Viatris Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 77. Viatris Recent Development

Table 78. Bayer Company Detail

Table 79. Bayer Business Overview

Table 80. Bayer Menopause Drugs Product

Table 81. Bayer Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 82. Bayer Recent Development

Table 83. Teva Company Detail

Table 84. Teva Business Overview

Table 85. Teva Menopause Drugs Product

Table 86. Teva Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 87. Teva Recent Development

Table 88. Novartis Company Detail

Table 89. Novartis Business Overview

Table 90. Novartis Menopause Drugs Product

Table 91. Novartis Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 92. Novartis Recent Development

Table 93. Abbott Company Detail

Table 94. Abbott Business Overview

Table 95. Abbott Menopause Drugs Product

Table 96. Abbott Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 97. Abbott Recent Development

Table 98. Roche Company Detail

Table 99. Roche Business Overview

Table 100. Roche Menopause Drugs Product

Table 101. Roche Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 102. Roche Recent Development

Table 103. Endo International Company Detail

Table 104. Endo International Business Overview

Table 105. Endo International Menopause Drugs Product

Table 106. Endo International Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 107. Endo International Recent Development

Table 108. Ipsen Company Detail

Table 109. Ipsen Business Overview

Table 110. Ipsen Menopause Drugs Product

Table 111. Ipsen Revenue in Menopause Drugs Business (2019-2024) & (US$ Million)

Table 112. Ipsen Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Menopause Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Menopause Drugs Market Share by Type: 2023 VS 2030

Figure 3. Parenteral Features

Figure 4. Transdermal Features

Figure 5. Oral Features

Figure 6. Others Features

Figure 7. Global Menopause Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Menopause Drugs Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Drugstores Case Studies

Figure 11. Others Case Studies

Figure 12. Menopause Drugs Report Years Considered

Figure 13. Global Menopause Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Menopause Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Menopause Drugs Market Share by Region: 2023 VS 2030

Figure 16. Global Menopause Drugs Market Share by Players in 2023

Figure 17. Global Top Menopause Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopause Drugs as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Menopause Drugs Revenue in 2023

Figure 19. North America Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Menopause Drugs Market Share by Country (2019-2030)

Figure 21. United States Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Menopause Drugs Market Share by Country (2019-2030)

Figure 25. Germany Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Menopause Drugs Market Share by Region (2019-2030)

Figure 33. China Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Menopause Drugs Market Share by Country (2019-2030)

Figure 41. Mexico Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Menopause Drugs Market Share by Country (2019-2030)

Figure 45. Turkey Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Menopause Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Eli Lilly Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 48. Pfizer Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 49. AbbVie Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 50. Novo Nordisk Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 51. Merck KGaA Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 52. Viatris Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 53. Bayer Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 54. Teva Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 55. Novartis Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 56. Abbott Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 57. Roche Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 58. Endo International Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 59. Ipsen Revenue Growth Rate in Menopause Drugs Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Cervical Reactor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36N12563

Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Sheath Dilators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22G13190

Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Global Umbilical Cord Clamp Clipper Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-19Y10769

Thu Mar 21 00:00:00 UTC 2024

Add to Cart

Global Pelvic Plate Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9W12966

Thu Mar 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions